Noninvasive cartilage imaging to predict early osteoarthritis
Official title: Noninvasive Imaging of Cartilage Elastography to Probe Osteoarthritis Pathogenesis
Funded at University of Colorado · NIH-11447928 · Data updated 2026-11-12
A noninvasive MRI method called dualMRI will be tested to see if it can predict early joint degeneration before pain or scans show OA.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project start | September 1, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $578,289 |
| NIH project number | 1R01AR086835-01A1 |
| Project ID | NIH-11447928 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with risk factors for OA, including prior ACL injury or repair, and those undergoing ACL-related evaluation or follow-up.
✕Less likely to help
Patients without risk factors or pre-OA changes may not benefit from this imaging biomarker.
What this research studies
This project aims to translate and validate a new MRI technique that measures cartilage biomechanics to identify people at risk of developing osteoarthritis after joint injuries. Researchers will test dualMRI in living patients to see if the imaging biomarkers predict early, pre-OA changes before classic symptoms appear. The work combines advanced imaging with analysis of how cartilage responds to load, hoping to identify a sensitive tool for early intervention. The study involves collaboration between the University of Colorado and clinical teams to move promising biomarkers toward regulatory review.
Why it matters
Potential benefit: If successful, patients at risk for osteoarthritis could be identified earlier and receive interventions to slow disease progression.
How similar studies have gone: Prior work has shown promise for imaging biomarkers in OA, but this approach is novel in its specific measurement of cartilage biomechanics to predict pre-OA.
Where this research is happening
-
University of Colorado
Boulder, United States Active
Researchers
- Principal investigator: Neu, Corey P — University of Colorado
- Study coordinator: Neu, Corey P
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.